LDHA and cancer: Our data showed a positive correlation between lactate accumulation and RHOA lactylation and confirmed that the LDHA inhibitor oxamate inhibited the migration and invasion of cancer cells with RHOA lactylation, suggesting that inhibiting lactate production could be a potential therapeutic approach for patients with lactylated RHOA-driven tumors.